1[1]Baker KM.Booz GW.Dostal D E. Catdiac actions of angiotensin Ⅱ role of an intracardiacrenin -angiotensin systems[J]. Annu Rev Physiol. 1997. 54 :227L-241 L.
2[2]Izumi Y.Kim S.Zhan Y.et al. Important role of angiotensin Ⅱ-mediated e-Jun NH(2 )-terminal kinese activation in cardiac hypertrophy is hypertensive rats [J]. Hypertension,2000,36(4) :511-516.
3[3]Suzuki J, Matsubara H, Urakami M et al. Rat angiotensin Ⅱ(type 1A) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy [J]. Cire Res, 1993,73 ( 3 ) :439-447.
4[4]Aceto JF.Baker KM. [SarI]angiotensin Ⅲ receptor-mediated stimulation of protein synthesis in chick heart cells[J]. Am J Physiol,1990.258(3 Pt 2) :H806-H813.
5[5]Harada M,Itoh H,Nakagawa O,et al. Sigaificance of ventricular myocytes and nommyocytes interaction during cardiocyte hypertrophy:evideace for endothelin-1 as a paracrine hypertrophic factor from cardiac nonmyooytes [ J ]. Circulation.1997 ,96( 10 ) :3737-3744.
6[6]Mazzolai L,Pedrazzini T,Nicoud F,et al. Increased cardiac angiotensin Ⅱ levels induce right and left ventricular hypertrophy in normotensive mice [ J ]. Hypoertension.2000,35 (4) :985-991.
7[7]Harada K, Komuro I ,Zou Y ,et al. Aeute pressure overlond could induce hypertrophic responses in the heart of angiotensin Ⅱ type la kmockout mice[ J]. Cire Res, 1998,82 (7) :779-785.
8[8]Kajstura J,Cigola E. Malhotra A. et al. Angiotensin Ⅱ induces apoposis of ventricularmyocytes in vitro[ J ]. J Mol Cell Cardiol, 1997,29( 3 ) :859-870.
9[9]Pierzchalaki P.Reiss K,Cheng W,et al. p53 Induces myocyte apoptosis via the activation of therenin-angioteasin system[J]. Exp Cell Res, 1997.234 ( 1 ) :57-65.
10[10]Leri A,Claudio PP, Li Q,et al. Stretch-mediated release of angiotensin Ⅱ induces myocyte apoptosis by activatin p53 that enhances the local rennin-angiotensin system and decreases the Bcl-2-to-Bax Protein ratio in the cell [ J ]. J Clin Invest, 1998, 101 (7) : 1326-1342.
3Anné W,Willems B,Roskams T,et al.Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation[J].Cardiovasc Res,2005,67(4):655.
4Lijnen P,Petrov V.Induction of cardiac fibrosis by Aldosterone[J].J Mol Cell Cardiol,2000,32(6):865.
5Dixen U,Ravn L,Soeby-Rasmussen C,et al.Raised plasma Aldosterone and natriuretic peptides in atrial fibrillation[J].Cardiology,2007,108(1):35.
6Heymes C,Garnier A,Fuchs S,et al.Aldosterone-synthase overexpression in heart:a tool to explore Aldosterone's effects[J].Mol Cell Endocrinol,2004,217(1-2):213.
7Delcayre C,Silvestre JS,Garnier A,et al.Cardiac Aldosterone production and ventricular remodeling[J].Kidney Int,2000,57(3):1346.
8Korantzopoulos P,Goudevenos JA.Aldosterone signaling in atrial fibrillation another piece in the puzzle of atrial remodeling[J].Am Coll Cardiol,2010,55(8):771.
9Tsybouleva N,Zhang L,Chen S,et al.Aldosterone,through novel signaling proteins,is a fundamental molecular bridgebetween the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy[J].Circulation,2004,109(10):1284.
10Peifley KA,Winkles JA.Angiotensin Ⅱ and endothelin-1 increase fibroblast growth factor-2 mRNA expression in vascular smooth muscle cells[J].Biochem Biophys Res Commun,1998,242(1):202.
